Home / 2011 / November (page 4)

Monthly Archives: November 2011

Oral Insulin Substitute Could Replace Injections

Erik Helmerhorst, professor at Curtin University, and colleagues, looked at three million compounds on pharmaceutical databases over 10 years to try to emulate the molecular map of insulin. They found one, and are developing it to “take the needle out of diabetes.” “Our innovation is the development of a new …

Read More »

Patients Want More Engagement with Doctors

Patients are looking for doctors who will check up on them and offer guidance between office visits according to a new report, “A Fragile Nation in Poor Health,” a look at why patients don’t follow their doctors’ treatment plans and what solutions are available to the healthcare community. Eighty-three percent …

Read More »

Rosiglitazone Restricted to Mail

Diabetes drugs with rosiglitazone are now available only through certified mail-order pharmacies. Doctors wishing to prescribe the drugs and patients planning to continue taking them should enroll in GlaxoSmithKline’s Avandia Rosiglitazone Medicines Access Program. As of November 18, Avandia (rosiglitazone maleate), Avandamet (rosiglitazone maleate and metformin hydrochloride), and Avandaryl (rosiglitazone …

Read More »

Pig Transplant Boosts Diabetes Hopes

A pig’s pancreatic islets were transplanted into a diabetic monkey which was then administered a newly developed immune-regulating antibody. As a result, the monkey’s blood-sugar level was automatically controlled without any rejection, and has been healthy for the last six months….

Read More »